scholarly article | Q13442814 |
P2093 | author name string | Fu L | |
Benchimol S | |||
Minden MD | |||
P2860 | cites work | Isolation and characterization of a human p53 cDNA clone: expression of the human p53 gene | Q24555633 |
cDNA encoding the human homologue of rat ribosomal protein L35a | Q24609296 | ||
Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease | Q26778460 | ||
A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity | Q26778490 | ||
Efficientin vitrosynthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter | Q27861016 | ||
Amplification of a gene encoding a p53-associated protein in human sarcomas | Q28270924 | ||
The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation | Q28280958 | ||
The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53 | Q29547773 | ||
Participation of p53 protein in the cellular response to DNA damage | Q29618319 | ||
Monoclonal antibodies specific for simian virus 40 tumor antigens | Q34249232 | ||
Wild-type p53 protein undergoes cytoplasmic sequestration in undifferentiated neuroblastomas but not in differentiated tumors | Q34330309 | ||
Expression of different conformations of p53 in the blast cells of acute myeloblastic leukaemia is related to in vitro growth characteristics | Q35977787 | ||
Various rat adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphate-dehydrogenase multigenic family | Q36136925 | ||
Altered conformation of the p53 protein in myeloid leukemia cells and mitogen-stimulated normal blood cells | Q36322555 | ||
Expression of the p53 oncogene in acute myeloblastic leukemia | Q36352855 | ||
Molecular cloning and in vitro expression of a cDNA clone for human cellular tumor antigen p53. | Q36489098 | ||
Cloning and sequencing of a human 18S ribosomal RNA gene | Q36498808 | ||
Induction of cellular p53 activity by DNA-damaging agents and growth arrest. | Q36690595 | ||
p53 cellular tumor antigen: analysis of mRNA levels in normal adult tissues, embryos, and tumors | Q36895398 | ||
Two distinct mechanisms alter p53 in breast cancer: mutation and nuclear exclusion | Q37142419 | ||
A method to detect and characterize point mutations in transcribed genes: amplification and overexpression of the mutant c-Ki-ras allele in human tumor cells | Q37554584 | ||
Functional inactivation but not structural mutation of p53 causes liver cancer. | Q38300638 | ||
Translational regulation of nanos by RNA localization | Q40388924 | ||
An improved method for directly sequencing PCR amplified material using dimethyl sulphoxide | Q40521534 | ||
Probable clonal origin of acute myeloblastic leukemia following radiation and chemotherapy of colon cancer | Q40551929 | ||
Characterization of the human p53 gene promoter | Q40648046 | ||
Binding of a phosphoprotein to the 3' untranslated region of the mouse protamine 2 mRNA temporally represses its translation | Q40656422 | ||
The HRIGRXXR region of the DEAD box RNA helicase eukaryotic translation initiation factor 4A is required for RNA binding and ATP hydrolysis | Q40656567 | ||
Primary structure polymorphism at amino acid residue 72 of human p53. | Q40658642 | ||
Characterization of the human p53 gene | Q40669877 | ||
Separation of blast cell and T-lymphocyte progenitors in the blood of patients with acute myeloblastic leukemia | Q40711351 | ||
Translational regulation by mRNA/protein interactions in eukaryotic cells: ferritin and beyond | Q40895484 | ||
The 5' region of the p53 gene: evolutionary conservation and evidence for a negative regulatory element | Q41430095 | ||
Differential induction of transcriptionally active p53 following UV or ionizing radiation: defects in chromosome instability syndromes? | Q41513765 | ||
Mutations of the p53 gene in myelodysplastic syndrome (MDS) and MDS-derived leukemia. | Q41548934 | ||
Induction of nuclear accumulation of the tumor-suppressor protein p53 by DNA-damaging agents | Q41575832 | ||
Analysis of the gene coding for the murine cellular tumour antigen p53 | Q41580458 | ||
Levels of p53 protein increase with maturation in human hematopoietic cells | Q41669503 | ||
Mutation of the p53 gene in human acute myelogenous leukemia | Q41688717 | ||
Expression of a retinoic acid receptor gene in myeloid leukemia cells | Q42008263 | ||
In situ hybridization and immunohistochemistry of p53 tumor suppressor gene in human esophageal carcinoma | Q42050334 | ||
Translational potentiation of messenger RNA with secondary structure in Xenopus | Q43655832 | ||
HIV-1 tat trans-activation requires the loop sequence within tar. | Q44349676 | ||
P53 gene mutations in acute myeloid leukemia with 17p monosomy. | Q46116390 | ||
Isolation of high-molecular-weight DNA from eukaryotic cells by formamide treatment and dialysis | Q47194408 | ||
Translational control of maternal glp-1 mRNA establishes an asymmetry in the C. elegans embryo | Q49107678 | ||
Translational regulation of tra-2 by its 3' untranslated region controls sexual identity in C. elegans | Q49130284 | ||
Transient translational silencing by reversible mRNA deadenylation | Q50792056 | ||
Surface antigenic profile and globin phenotype of two new human erythroleukemia lines: characterization and interpretations. | Q51186144 | ||
Isolation of human-p53-specific monoclonal antibodies and their use in the studies of human p53 expression. | Q54422442 | ||
Human wild-type p53 adopts a unique conformational and phosphorylation state in vivo during growth arrest of glioblastoma cells | Q55483452 | ||
Mutations of the p53 gene in lymphoid leukemia | Q67683874 | ||
Mutations of the P53 gene in acute myeloid leukaemia | Q68077839 | ||
A conformation hypothesis for the suppressor and promoter functions ofp53in cell growth control and in cancer | Q68323916 | ||
Analysis of human p53 proteins and mRNA levels in normal and transformed cells | Q68954945 | ||
Expression of p53 gene in 184 unifocal hepatocellular carcinomas: association with tumor growth and invasiveness | Q70487570 | ||
Analysis of p53 gene mutations in acute myeloid leukemia | Q72074767 | ||
Cytoplasmic regulation of mRNA function: The importance of the 3′ untranslated region | Q72088073 | ||
Myelodysplastic syndromes and acute myeloid leukemia with 17p deletion. An entity characterized by specific dysgranulopoïesis and a high incidence of P53 mutations | Q72618160 | ||
p53 mutations are associated with resistance to chemotherapy and short survival in hematologic malignancies | Q72776851 | ||
P433 | issue | 16 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 4392-4401 | |
P577 | publication date | 1996-08-01 | |
P1433 | published in | The EMBO Journal | Q1278554 |
P1476 | title | Translational regulation of human p53 gene expression | |
P478 | volume | 15 |
Q36754697 | A p53-dependent S-phase checkpoint helps to protect cells from DNA damage in response to starvation for pyrimidine nucleotides |
Q73270731 | A translation repressor element resides in the 3' untranslated region of human p53 mRNA |
Q35882548 | Accumulation of p53 induced by the adenovirus E1A protein requires regions involved in the stimulation of DNA synthesis. |
Q40666171 | BCR/ABL activates mdm2 mRNA translation via the La antigen |
Q36691968 | Bcl-2/Bax protein ratio predicts 5-fluorouracil sensitivity independently of p53 status |
Q26744030 | Cap-Independent Translational Control of Carcinogenesis |
Q40643483 | Comparison of p53 mutational status with mRNA and protein expression in a panel of 24 human breast carcinoma cell lines |
Q48328376 | Conservation of mononucleotide repeats within 3' and 5' untranslated regions and their instability in MSI-H colorectal cancer |
Q33997846 | Dial 9-1-1 for p53: mechanisms of p53 activation by cellular stress |
Q81455993 | Do peptides control their own birth and death? |
Q34260692 | Effect of 2'-O-methyl antisense ORNs on expression of thymidylate synthase in human colon cancer RKO cells |
Q24338148 | Eukaryotic translation initiation factor 5A induces apoptosis in colon cancer cells and associates with the nucleus in response to tumour necrosis factor alpha signalling |
Q73112510 | Expression of p53 and mdm2 mRNA and protein in colorectal carcinomas |
Q40230329 | Expression of p53 and p53/47 are controlled by alternative mechanisms of messenger RNA translation initiation |
Q95751079 | Expression profiling reveals fundamental biological differences in acute myeloid leukemia with isolated trisomy 8 and normal cytogenetics |
Q35268497 | Generation of oscillations by the p53-Mdm2 feedback loop: a theoretical and experimental study |
Q33337762 | Having it both ways: transcription factors that bind DNA and RNA. |
Q74521322 | High sensitivity of the ultraviolet-induced p53 response in ultraviolet-sensitive syndrome, a photosensitive disorder with a putative defect in deoxyribonucleic acid repair of actively transcribed genes |
Q40771473 | Immortal and mortal clonal lymphocyte lines from channel catfish: comparison of telomere length, telomerase activity, tumor suppressor and heat shock protein expression. |
Q38370358 | Implications of miRNAs in Colorectal Cancer Chemoresistance |
Q35565247 | Implications of microRNAs in colorectal cancer development, diagnosis, prognosis, and therapeutics |
Q42630918 | Induced N- and C-terminal cleavage of p53: a core fragment of p53, generated by interaction with damaged DNA, promotes cleavage of the N-terminus of full-length p53, whereas ssDNA induces C-terminal cleavage of p53 |
Q42087264 | Inducible activation of CEBPB, a gene negatively regulated by BCR/ABL, inhibits proliferation and promotes differentiation of BCR/ABL-expressing cells |
Q78171317 | Inhibition of RNA polymerase II as a trigger for the p53 response |
Q36173829 | Inhibition of autophagy and tumor growth in colon cancer by miR-502. |
Q92137102 | Integrated Regulation of HuR by Translation Repression and Protein Degradation Determines Pulsatile Expression of p53 Under DNA Damage |
Q41827348 | Interplay between RNA-binding protein HuR and microRNA-125b regulates p53 mRNA translation in response to genotoxic stress |
Q37031910 | Investigation of miRNA biology by bioinformatic tools and impact of miRNAs in colorectal cancer--regulatory relationship of c-Myc and p53 with miRNAs |
Q33737801 | Isoform-specific p73 knockout mice reveal a novel role for delta Np73 in the DNA damage response pathway |
Q58544657 | KDM5A Regulates a Translational Program that Controls p53 Protein Expression |
Q47786180 | Keeping an old friend under control: regulation of p53 stability |
Q91695282 | LSD1/KDM1A inhibitors in clinical trials: advances and prospects |
Q28138926 | MDM2--master regulator of the p53 tumor suppressor protein |
Q89379344 | Measuring cell cycle-dependent DNA damage responses and p53 regulation on a cell-by-cell basis from image analysis |
Q37154118 | MiR-20a-5p represses multi-drug resistance in osteosarcoma by targeting the KIF26B gene |
Q38706599 | MicroRNA-451 regulates chemoresistance in renal cell carcinoma by targeting ATF-2 gene |
Q35561593 | MicroRNAs and cancer |
Q33895297 | Molecular mechanism of chemoresistance by miR-215 in osteosarcoma and colon cancer cells |
Q31148862 | Mutation and expression of the p53 gene during chemical hepatocarcinogenesis in F344 rats |
Q38107795 | Nucleolar control of p53: a cellular Achilles' heel and a target for cancer therapy. |
Q33887029 | Participation of the human p53 3'UTR in translational repression and activation following gamma-irradiation |
Q35545143 | Phosphorylation of serine 18 regulates distinct p53 functions in mice |
Q33916603 | Pidd, a new death-domain-containing protein, is induced by p53 and promotes apoptosis |
Q33771772 | Polysome trafficking of transcripts and microRNAs in regenerating liver after partial hepatectomy |
Q28387511 | Posttranscriptional regulation of p53 and its targets by RNA-binding proteins |
Q24681379 | Prognostic Values of microRNAs in Colorectal Cancer |
Q36077545 | Prognostic significance of miR-215 in colon cancer |
Q54075746 | RNA synthesis block by 5, 6-dichloro-1-beta-D-ribofuranosylbenzimidazole (DRB) triggers p53-dependent apoptosis in human colon carcinoma cells. |
Q36451021 | Regulation of p53 expression by thymidylate synthase |
Q35883364 | Regulation of p53 levels by the E1B 55-kilodalton protein and E4orf6 in adenovirus-infected cells. |
Q34075723 | Role of programmed cell death in development |
Q33903996 | The 3' untranslated region of messenger RNA: A molecular 'hotspot' for pathology? |
Q28144828 | The double-stranded RNA activated protein kinase PKR physically associates with the tumor suppressor p53 protein and phosphorylates human p53 on serine 392 in vitro |
Q26742058 | The expanding regulatory universe of p53 in gastrointestinal cancer |
Q64069116 | The p53 mRNA: an integral part of the cellular stress response |
Q28207340 | Thymidylate synthase as a translational regulator of cellular gene expression |
Q28584078 | Thymidylate synthase protein and p53 mRNA form an in vivo ribonucleoprotein complex |
Q38660230 | Translational control of human p53 expression in yeast mediated by 5'-UTR-ORF structural interaction |
Q42051478 | miR-129 promotes apoptosis and enhances chemosensitivity to 5-fluorouracil in colorectal cancer |
Q37764707 | miRNAs as biomarkers in colorectal cancer diagnosis and prognosis |
Q74183048 | p53 Stability and activity is regulated by Mdm2-mediated induction of alternative p53 translation products |
Q40714283 | p53 activation results in rapid dephosphorylation of the eIF4E-binding protein 4E-BP1, inhibition of ribosomal protein S6 kinase and inhibition of translation initiation |
Q37502697 | p53 and little brother p53/47: linking IRES activities with protein functions |
Q42829713 | p53 protein accumulation in addition to the transactivation activity is required for p53-dependent cell cycle arrest after treatment of cells with camptothecin. |
Q37385633 | p53-Dependent and -independent responses to cisplatin in mouse testicular teratocarcinoma cells |
Q41345451 | p53; from inductive signal to cellular effect |
Search more.